Enzo Life Sciences SARS-CoV-2 IgG ELISA kit

The characterisation of the SARS-CoV-2 virus is critical for understanding the mechanisms of action of the virus, including the viral entry into the host cells, the replication cycle and the viral spread into human body. A better understanding of those biological processes is key for a better diagnosis and treatment of the disease.

Enzo Life Sciences provides a full range of tools including antibodies, antigens and assay kits that help investigate different aspects of the biology of the SARS-CoV-2 virus. The company now offers a SARS-CoV-2 IgG ELISA Kit for in vitro diagnostic use under the FDA’s Emergency Use Authorization (EUA).

Enzo’s ELISA assay is a qualitative assay, optimised to provide accurate and sensitive detection of IgG antibodies to SARS-CoV-2 in human serum, with high throughput testing capabilities for the clinical laboratory setting. The ELISA kit is a colorimetric immunoassay kit with results in under 2 h. Absorbance is read at 450 nm and can be used to measure up to 86 samples per kit, with all necessary reagents supplied.